Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 16

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 16
---
 our annual revenue is less than $100 million during the most recently completed fiscal year. As such, we are eligible for exemptions from various reporting requirements applicable to other public companies that are not smaller reporting companies, including, but not limited to, reduced disclosure obligations regarding executive compensation. We may continue to be a smaller reporting company as long as either (i) the market value of our common shares held by non-affiliates is less than $250 million or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our common shares held by non-affiliates is less than $700 million.

<div align='center'>6

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.

PURSUANT TO 17 C.F.R. SECTION 200.83

THE OFFERING</div>

This summary highlights information presented in greater detail elsewhere in this prospectus. This summary is not complete and does not contain all the information you should consider before investing in our securities. You should carefully read this entire prospectus before investing in our securities, including "Risk Factors" and our consolidated financial statements.

| Issuer                                        | Medicus Pharma Ltd.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Securities offered by the Selling Shareholder | 1,397,184 common shares                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Terms of the offering                         | Each Selling Shareholder will determine when and how it will dispose of any common shares registered under this prospectus for sale.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Common shares to be outstanding               | 21,615,288 common shares                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Use of Proceeds                               | We will not receive any proceeds from the sale of the common shares offered by this prospectus by the Selling Shareholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Voting rights                                 | Each outstanding common share will be entitled to one vote on all matters submitted to a vote of shareholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Listing                                       | Our common shares are listed on the Nasdaq under the symbol "MDCX".                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dividend policy                               | We do not anticipate that we will declare or pay dividends in the foreseeable future on our common shares. Instead, we anticipate that all of our earnings will be used for the operation and growth of our business. Any future determination to declare cash dividends would be subject to the discretion of our board of directors and would depend upon various factors, including our results of operations, financial condition and liquidity requirements, restrictions